Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.

ABSTRACT:

Background

Following introduction of antimycobacterial treatment of Buruli ulcer disease (BUD), several clinical studies evaluated treatment outcomes of BUD patients, in particular healing times, secondary lesions and functional limitations. Whereas recurrences were rarely observed, paradoxical reactions and functional limitations frequently occurred. Although systematic BUD control in Togo was established as early as 2007, treatment outcome has not been reviewed to date. Therefore, a pilot project on post-treatment follow-up of BUD patients in Togo aimed to evaluate treatment outcomes and to provide recommendations for optimization of treatment success.

Methodology/principal findings

Out of 199 laboratory confirmed BUD patients, 129 could be enrolled in the study. The lesio

SUBMITTER: Beissner M 

PROVIDER: S-EPMC4608783 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature